Literature DB >> 16782384

Persistent brain infection and disease reactivation in relapsing fever borreliosis.

Christer Larsson1, Marie Andersson, Jenni Pelkonen, Betty P Guo, Annika Nordstrand, Sven Bergström.   

Abstract

Relapsing fever, an infection caused by Borrelia spirochetes, is generally considered a transient, self-limiting disease in humans. The present study reveals that murine infection by Borrelia duttonii can be reactivated after an extended time as a silent infection in the brain, with no bacteria appearing in the blood and spirochete load comparable to the numbers in an infected tick. The host cerebral gene expression pattern is indistinguishable from that of uninfected animals, indicating that persistent bacteria are not recognized by the immune system nor cause noticeable tissue damage. Silent infection can be reactivated by immunosuppression, inducing spirochetemia comparable to that of initial densities. B. duttonii has never been found in any host except man and the tick vector. We therefore propose the brain to be a possible natural reservoir of the spirochete. The view of relapsing fever as an acute disease should be extended to include in some cases prolonged persistence, a feature characteristic of the related spirochetal infections Lyme disease and syphilis.

Entities:  

Mesh:

Year:  2006        PMID: 16782384     DOI: 10.1016/j.micinf.2006.04.007

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  13 in total

1.  Interleukin 10 protects the brain microcirculation from spirochetal injury.

Authors:  Diana Londoño; Jenny Carvajal; Carolina Arguelles-Grande; Adriana Marques; Diego Cadavid
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

2.  Concomitant infection decreases the malaria burden but escalates relapsing fever borreliosis.

Authors:  Jenny Lundqvist; Christer Larsson; Maria Nelson; Marie Andersson; Sven Bergström; Cathrine Persson
Journal:  Infect Immun       Date:  2010-02-09       Impact factor: 3.441

3.  Outer membrane protein sequence variation in lambs experimentally infected with Anaplasma phagocytophilum.

Authors:  Erik G Granquist; Snorre Stuen; Anna M Lundgren; Margrethe Bråten; Anthony F Barbet
Journal:  Infect Immun       Date:  2007-10-29       Impact factor: 3.441

4.  Real-time monitoring of disease progression in rhesus macaques infected with Borrelia turicatae by tick bite.

Authors:  Job E Lopez; Heather Vinet-Oliphant; Hannah K Wilder; Christopher P Brooks; Britton J Grasperge; Timothy W Morgan; Kerstan J Stuckey; Monica E Embers
Journal:  J Infect Dis       Date:  2014-05-30       Impact factor: 5.226

Review 5.  Understanding tropism and immunopathological mechanisms of relapsing fever spirochaetes.

Authors:  D Cadavid; D Londoño
Journal:  Clin Microbiol Infect       Date:  2009-05       Impact factor: 8.067

Review 6.  Pathogenesis of Relapsing Fever.

Authors:  Job Lopez; Joppe W Hovius; Sven Bergström
Journal:  Curr Issues Mol Biol       Date:  2020-12-29       Impact factor: 2.081

7.  Borrelia persica Infection in Immunocompetent Mice--A New Tool to Study the Infection Kinetics In Vivo.

Authors:  Sandra Schwarzer; Evelyn Overzier; Walter Hermanns; Gad Baneth; Reinhard K Straubinger
Journal:  PLoS Negl Trop Dis       Date:  2016-02-18

8.  Tick-Borne Relapsing Fever in Dogs.

Authors:  J Piccione; G J Levine; C A Duff; G M Kuhlman; K D Scott; M D Esteve-Gassent
Journal:  J Vet Intern Med       Date:  2016-06-28       Impact factor: 3.333

9.  A novel animal model of Borrelia recurrentis louse-borne relapsing fever borreliosis using immunodeficient mice.

Authors:  Christer Larsson; Jenny Lundqvist; Nico van Rooijen; Sven Bergström
Journal:  PLoS Negl Trop Dis       Date:  2009-09-29

10.  Sequence analysis and serological responses against Borrelia turicatae BipA, a putative species-specific antigen.

Authors:  Job E Lopez; Hannah K Wilder; William Boyle; L Brock Drumheller; Justin A Thornton; Bridget Willeford; Timothy W Morgan; Andrea Varela-Stokes
Journal:  PLoS Negl Trop Dis       Date:  2013-09-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.